Nemkova S A
Pirogov Russian National Research Medical University, Moscow, Russia.
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122(4):23-30. doi: 10.17116/jnevro202212204123.
To date, it is well established that neurological and neuropsychic disorders persist for a long time in a significant part of adult patients who have undergone COVID-19, despite the fact that there is much less information about the manifestations of postcovid syndrome (PCS) in children and adolescents. The review provides data on the features of the course of PCS in young patients, discusses the possibilities of treating such patients. The results of studies on the use of the drug Cortexin for the correction of cognitive and emotional disorders are analyzed.
迄今为止，已经明确的是，在感染过新冠病毒的成年患者中，很大一部分人的神经和神经精神障碍会长期存在，尽管关于儿童和青少年新冠后综合征（PCS）表现的信息要少得多。这篇综述提供了关于年轻患者PCS病程特点的数据，讨论了治疗这类患者的可能性。分析了使用药物脑蛋白水解物（Cortexin）纠正认知和情绪障碍的研究结果。
